Search results
Chicago Partners Investment Group LLC Has $239,000 Stock Position in Taysha Gene Therapies, Inc....
ETF DAILY NEWS· 1 day agoChicago Partners Investment Group LLC raised its holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 21.4% during the fourth quarter, according to its most ...
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 16 hours agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
Gene Therapy Improves Vision in Rare, Inherited Eye Disorder
Medscape· 1 day agoEDIT-101, a CRISPR-based gene editing therapy, shows promise in patients with retinal degeneration...
Taysha Gene Therapies’ (TSHA) “Buy” Rating Reaffirmed at Needham & Company LLC
ETF DAILY NEWS· 3 days agoTaysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a research report issued to clients ...
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 4.1%
ETF DAILY NEWS· 4 days agoTaysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) traded down 4.1% on Friday . The company traded as low as $3.95 and last traded at $4.00. 191,240 shares were traded ...
Genetic Technologies Limited (NASDAQ:GENE) Short Interest Up 495.3% in May
ETF DAILY NEWS· 6 days agoGenetic Technologies Limited (NASDAQ:GENE – Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short ...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 7 days agoPfizer is still evaluating its next steps, but Schwartz says it's unlikely Pfizer will move forward...
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 7 days agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 1.8%
ETF DAILY NEWS· 1 day agoShares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) dropped 1.8% on Monday . The stock traded as low as $61.36 and last traded at $62.40. Approximately 273,954 ...
What's Going On With Taysha Gene Therapies Stock Tuesday? - Taysha Gene Therapies (NASDAQ:TSHA)
Benzinga· 2 days agoTuesday, Taysha Gene Therapies Inc TSHA released longer-term clinical data from the ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from the ...